Georgia Capital PLC (LON:CGEO)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 1.18B |
| Revenue (ttm) | 541.27M |
| Net Income (ttm) | 445.54M |
| Shares Out | 30.05M |
| EPS (ttm) | n/a |
| PE Ratio | 2.66 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49,604 |
| Average Volume | 64,966 |
| Open | 3,935.00 |
| Previous Close | 3,940.00 |
| Day's Range | 3,850.00 - 3,940.00 |
| 52-Week Range | 1,604.00 - 4,190.00 |
| Beta | 0.63 |
| RSI | 49.15 |
| Earnings Date | Apr 28, 2026 |
About Georgia Capital
Georgia Capital PLC is a private equity and venture capital firm specializing in early stage, organic growth and acquisitions. It consider greenfields through mature stage companies. The firm typically invests in automotive retail, education services, hotels, resorts & cruise lines, restaurants, beverages, healthcare, banks, property and casualty insurance, life and health insurance, diversified REITs, water utilities, and renewable electricity. It seeks to invest in Georgia. The firm seeks board position in public portfolio companies. It exits... [Read more]
Financial Performance
In 2025, Georgia Capital's revenue was 1.90 billion, an increase of 415.81% compared to the previous year's 368.10 million. Earnings were 1.89 billion, an increase of 422.43%.
Financial numbers in GEL Financial StatementsNews
Georgia Capital Earnings Call Transcript: Q1 2026
NAV per share grew over 9% year-to-date, driven by strong portfolio company performance and buybacks. Retail Pharmacy, Healthcare, and Insurance segments all posted double-digit revenue and EBITDA growth, while capital return and expansion in Armenia remain strategic priorities.
Georgia Capital Earnings Call Transcript: H2 2025
EV per share rose 14.1% in Q4 and 61% for the year, driven by strong portfolio and macroeconomic performance. Capital return program is ahead of schedule, with 80% completed, and key segments—retail pharmacy, insurance, and healthcare—delivered double-digit growth and robust cash flow.
Georgia Capital Earnings Call Transcript: Q3 2025
NAV per share rose nearly 8% in Q3, driven by strong operating results and share buybacks. Retail pharmacy, insurance, and healthcare segments all posted double-digit growth, with record profitability and robust cash flow. Capital return and dividend programs are ahead of schedule.
Georgia Capital Earnings Call Transcript: H1 2025
NAV per share rose 17.7% in Q2, driven by strong revenue and EBITDA growth across all major segments. GEL 300 million buyback completed early; new GEL 700 million capital return program launched. Insurance achieved investment-grade rating, and all segments reported robust cash generation.
Georgia Capital Earnings Call Transcript: Q1 2025
NAV per share rose 11.2% in Q1, driven by strong revenue and EBITDA growth in private portfolio companies. Aggressive buybacks continued, with over 27% of shares repurchased, and dividend income per share increased 11.6%. Georgia's macro environment remains robust, supporting further growth.
Georgia Capital Earnings Call Transcript: Q4 2024
Record NAV and EBITDA growth were achieved, driven by strong portfolio company performance, major divestments, and significant share buybacks. Leverage declined, free cash flow surged, and the outlook remains positive with continued capital returns and robust macroeconomic conditions.
Georgia Capital Earnings Call Transcript: Q3 2024
NAV per share rose 6.2% in Q3, driven by strong portfolio company performance, record dividend inflows, and a major beer business sale at a 40% premium to NAV. Operating cash flow and EBITDA reached record highs, while buybacks reduced share count near demerger levels.
Georgia Capital Earnings Call Transcript: Q2 2024
NAV declined 12.8% in Q2 due to higher cost of equity and market volatility, despite strong EBITDA and revenue growth across portfolio companies. Buyback program expanded, with robust liquidity and positive macroeconomic outlook, though political risks remain.